Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Southern Medical University ; (12): 1632-1634, 2009.
Artigo em Chinês | WPRIM | ID: wpr-282629

RESUMO

<p><b>OBJECTIVE</b>To evaluate the bioequivalence of tiopronin enteric capsules (testing preparation, T) versus tablets (reference preparation, R).</p><p><b>METHODS</b>A single oral dose of tiopronin enteric capsules or tablets at 200 mg was administered in 2 groups of Chinese healthy volunteers (n=9) in a randomized crossover design at the interval of 2 weeks. The plasma concentrations of tiopronin were measured by HPLC-MS/MS, and the pharmacokinetic parameters were calculated by DAS 2.0 program. The bioequivalence between the two preparations was evaluated.</p><p><b>RESULTS</b>The main pharmacokinetic parameters were as follows: C(max)(microg.ml(-1)) 3.612-/+1.2393 (R), 3.644-/+1.540 (T); t(max) 4.333-/+1.0853 (R), 3.611-/+1.420 (T); t((1/2))(h) 18.245-/+11.270 (R), 23.403-/+10.500 (T); AUC0-t (microg.h.ml(-1)) 18.732-/+6.92318 (R), 18.713-/+6.585 (T); AUC0-infinity (microg.h.ml(-1)) 21.900-/+7.31220 (R), 20.780-/+7.965 (T). The relative bioavailability of tiopronin enteric capsule was 103.712-/+23.956%, with 90% confidential intervals of ln(AUC0-->72), ln(AUC0-infinity) and ln(C(max)) of 91.1%-111.8%, 96.8%-118.3%, and 85.1%-113.0%, respectively.</p><p><b>CONCLUSION</b>The tiopronin enteric capsules were bioequivalent to the tablets.</p>


Assuntos
Humanos , Masculino , Adulto Jovem , Disponibilidade Biológica , Cápsulas , Estudos Cross-Over , Saúde , Modelos Lineares , Reprodutibilidade dos Testes , Equivalência Terapêutica , Tiopronina , Farmacocinética
2.
Journal of Southern Medical University ; (12): 1820-1823, 2008.
Artigo em Chinês | WPRIM | ID: wpr-321808

RESUMO

<p><b>OBJECTIVE</b>To investigate the role of human adenovirus type 5 (Ad5) early-region 1A (E1A) in premature senescence of human fibroblasts induced by Ras activation.</p><p><b>METHODS</b>Human fibroblasts were cotransduced with E1A, E1A1-143, or their vector (BP) and Ha-RasV12 or its vector (WH). The growth curves and percentages of the apoptotic cells were determined.</p><p><b>RESULTS</b>Expression of E1A or Ha-RasV12 in human fibroblasts significantly inhibited the cell growth. Transduction of Ha-RasV12 along with E1A or E1A 1-143 into human fibroblast cells resulted in active and rapid cell proliferation.</p><p><b>CONCLUSION</b>E1A can rescue human fibroblasts from Ras-induced premature senescence, and the senescence bypassing activity of E1A resides in its NH2 terminus.</p>


Assuntos
Humanos , Proteínas E1A de Adenovirus , Genética , Metabolismo , Apoptose , Genética , Fisiologia , Transformação Celular Neoplásica , Genética , Metabolismo , Células Cultivadas , Senescência Celular , Genética , Fisiologia , Fibroblastos , Biologia Celular , Metabolismo , Genes ras , Fisiologia , Pele , Biologia Celular , Transfecção
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA